199 related articles for article (PubMed ID: 30238259)
1. Plasma metabonomics investigation reveals involvement of fatty acid oxidation in hematotoxicity in Chinese benzene-exposed workers with low white blood cell count.
Sun R; Xu K; Zhang Q; Jiang X; Man Z; Yin L; Zhang J; Pu Y
Environ Sci Pollut Res Int; 2018 Nov; 25(32):32506-32514. PubMed ID: 30238259
[TBL] [Abstract][Full Text] [Related]
2. Plasma metabolomics study reveals the critical metabolic signatures for benzene-induced hematotoxicity.
Guo X; Zhang L; Wang J; Zhang W; Ren J; Chen Y; Zhang Y; Gao A
JCI Insight; 2022 Jan; 7(2):. PubMed ID: 35076025
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
[TBL] [Abstract][Full Text] [Related]
4. Tissue acylcarnitine status in a mouse model of mitochondrial β-oxidation deficiency during metabolic decompensation due to influenza virus infection.
Tarasenko TN; Cusmano-Ozog K; McGuire PJ
Mol Genet Metab; 2018 Sep; 125(1-2):144-152. PubMed ID: 30031688
[TBL] [Abstract][Full Text] [Related]
5. Bezafibrate in skeletal muscle fatty acid oxidation disorders: a randomized clinical trial.
Ørngreen MC; Madsen KL; Preisler N; Andersen G; Vissing J; Laforêt P
Neurology; 2014 Feb; 82(7):607-13. PubMed ID: 24453079
[TBL] [Abstract][Full Text] [Related]
6. Effects of fasting, feeding and exercise on plasma acylcarnitines among subjects with CPT2D, VLCADD and LCHADD/TFPD.
Elizondo G; Matern D; Vockley J; Harding CO; Gillingham MB
Mol Genet Metab; 2020; 131(1-2):90-97. PubMed ID: 32928639
[TBL] [Abstract][Full Text] [Related]
7. Metabolome-wide association study of occupational exposure to benzene.
Rothman N; Vermeulen R; Zhang L; Hu W; Yin S; Rappaport SM; Smith MT; Jones DP; Rahman M; Lan Q; Walker DI
Carcinogenesis; 2021 Nov; 42(11):1326-1336. PubMed ID: 34606590
[TBL] [Abstract][Full Text] [Related]
8. Association between benzene exposure, serum levels of cytokines and hematological measures in Chinese workers: A cross-sectional study.
Wang J; Guo X; Chen Y; Zhang W; Ren J; Gao A
Ecotoxicol Environ Saf; 2021 Jan; 207():111562. PubMed ID: 33254416
[TBL] [Abstract][Full Text] [Related]
9. Investigation into variation of endogenous metabolites in bone marrow cells and plasma in C3H/He mice exposed to benzene.
Sun R; Zhang J; Yin L; Pu Y
Int J Mol Sci; 2014 Mar; 15(3):4994-5010. PubMed ID: 24658442
[TBL] [Abstract][Full Text] [Related]
10. Very long-chain acyl-coenzyme A dehydrogenase deficiency in Chinese patients: eight case reports, including one case of prenatal diagnosis.
Li X; Ding Y; Ma Y; Liu Y; Wang Q; Song J; Yang Y
Eur J Med Genet; 2015 Mar; 58(3):134-9. PubMed ID: 25652019
[TBL] [Abstract][Full Text] [Related]
11. Prediction of VLCAD deficiency phenotype by a metabolic fingerprint in newborn screening bloodspots.
Knottnerus SJG; Pras-Raves ML; van der Ham M; Ferdinandusse S; Houtkooper RH; Schielen PCJI; Visser G; Wijburg FA; de Sain-van der Velden MGM
Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165725. PubMed ID: 32061778
[TBL] [Abstract][Full Text] [Related]
12. A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis.
Hisahara S; Matsushita T; Furuyama H; Tajima G; Shigematsu Y; Imai T; Shimohama S
Tohoku J Exp Med; 2015 Apr; 235(4):305-10. PubMed ID: 25843429
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific strategies of the very-long chain acyl-CoA dehydrogenase-deficient (VLCAD-/-) mouse to compensate a defective fatty acid β-oxidation.
Tucci S; Herebian D; Sturm M; Seibt A; Spiekerkoetter U
PLoS One; 2012; 7(9):e45429. PubMed ID: 23024820
[TBL] [Abstract][Full Text] [Related]
14. Are polymorphisms in metabolism protective or a risk for reduced white blood cell counts in a Chinese population with low occupational benzene exposures?
Ye LL; Zhang GH; Huang JW; Li Y; Zheng GQ; Zhang DT; Zhou LF; Tao XD; Zhang J; Ye YJ; Sun P; Frank A; Xia ZL
Int J Occup Environ Health; 2015; 21(3):232-40. PubMed ID: 26179485
[TBL] [Abstract][Full Text] [Related]
15. One potential hotspot ACADVL mutation in Chinese patients with very-long-chain acyl-coenzyme A dehydrogenase deficiency.
Li X; Ma R; Liu Y; Kang L; He R; Song J; Ren J; Li Y; Huang M; Men J; Yang Y
Clin Chim Acta; 2020 Apr; 503():218-222. PubMed ID: 31794763
[TBL] [Abstract][Full Text] [Related]
16. Elevations of C14:1 and C14:2 Plasma Acylcarnitines in Fasted Children: A Diagnostic Dilemma.
Burrage LC; Miller MJ; Wong LJ; Kennedy AD; Sutton VR; Sun Q; Elsea SH; Graham BH
J Pediatr; 2016 Feb; 169():208-13.e2. PubMed ID: 26602010
[TBL] [Abstract][Full Text] [Related]
17. The effect of valinomycin in fibroblasts from patients with fatty acid oxidation disorders.
Ndukwe Erlingsson UC; Iacobazzi F; Liu A; Ardon O; Pasquali M; Longo N
Biochem Biophys Res Commun; 2013 Aug; 437(4):637-41. PubMed ID: 23867825
[TBL] [Abstract][Full Text] [Related]
18. PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders.
Djouadi F; Bastin J
J Inherit Metab Dis; 2008 Apr; 31(2):217-25. PubMed ID: 18392740
[TBL] [Abstract][Full Text] [Related]
19. Should the beneficial impact of bezafibrate on fatty acid oxidation disorders be questioned?
Bastin J; Bonnefont JP; Djouadi F; Bresson JL
J Inherit Metab Dis; 2015 Mar; 38(2):371-2. PubMed ID: 25310995
[No Abstract] [Full Text] [Related]
20. Prolonged QT interval and lipid alterations beyond β-oxidation in very long-chain acyl-CoA dehydrogenase null mouse hearts.
Gélinas R; Thompson-Legault J; Bouchard B; Daneault C; Mansour A; Gillis MA; Charron G; Gavino V; Labarthe F; Des Rosiers C
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H813-23. PubMed ID: 21685264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
